Risk factors of peptic ulcer disease: Different impact of Helicobacter pylori in Dutch and Japanese populations?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 11, Issue 9, 1996, Pages 825-831

  Schlemper, Ronald J ^a,c   Van Der Werf, Sjoerd D J ^b   Vandenbroucke, Jan P ^a   Biemond, Izäk ^a   Lamers, Cornelis B H W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c SHOWA UNIVERSITY FUJIGAOKA HOSPITAL   (Japan)

Author keywords

Coffee; Duodenal ulcer; Gastric ulcer; Helicobacter pylori; Pepsinogen; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; DUODENUM ULCER; FEMALE; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PRIORITY JOURNAL; RISK FACTOR; STOMACH ULCER;

EID: 0029840883     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1996.tb00087.x     Document Type: Article

References (38)

1. Zane M. Psychosomatic considerations in peptic ulcer. Psychosom. Med. 1947; 2: 372-80.
2. Weiner H, Thaler M, Reiser MF, Mirsky IA. Etiology of duodenal ulcer. I. Relation of specific psychological characteristics to rate of gastric secretion (serum pepsinogen). Psychosom. Med. 1957; 19: 1-10.
3. Weiner H. From simplicity to complexity (1950-1990): The case of peptic ulceration. I. Human studies. Psychosom. Med. 1991; 53: 467-90.
4. Friedman GD, Siegelaub AB, Seltzer CC. Cigarettes, alcohol, coffee and peptic ulcer. N. Engl. J. Med. 1974; 290: 469-73.
5. Kurata JH. An assessment of nonsteroidal anti-inflammatory drugs as a risk factor in ulcer disease. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann. Intern. Med. 1991; 114: 307-19.
6. Langman MJS. Blood groups and alimentary disorders. Clin. Gastroenterol. 1973; 2: 497-506.
7. Rotter JI, Sones JQ, Samloff IM et al. Duodenal-ulcer disease associated with elevated serum pepsinogen I. An inherited autosomal dominant disorder. N. Engl. J. Med. 1979; 300: 63-6.
8. Marshall BJ, Warren JB. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311-15.
9. Rothman KJ. Causes. Am. J. Epidemiol. 1976; 104: 587-92.
10. Schlemper RJ, van der Werf SDJ, Vandenbroucke JP, Biemond I, Lamers CBHW. Peptic ulcer, non-ulcer dyspepsia and irritable bowel syndrome in The Netherlands and Japan. Scand. J. Gastroenterol. 1993; 28 (Suppl. 200): 33-41.
11. Peña AS, Endtz HPH, Offerhaus GJA et al. Value of serology (ELJSA and immunoblotting) for the diagnosis of Campylobacter pyloninfection. Digestion 1989; 44: 131-41.
12. Veenendaal RA, Peña AS, Kuiper I, van Duijn W, Lamers CBHW. Diagnostic value of the local and systemic antibody response to Helicobacter pylori infection. Irish J. Med. Sci. 1992; 161 (Suppl. 10): 76-7 (Abstract).
13. Biemond I, Jansen JBMJ, Crobach LFSJ, Kreuning J, Lamers CBHW. Radioimmunoassay of human pepsinogen A and pepsinogen C. Eur. J. Clin. Chem. Clin. Biochem. 1989; 27: 19-25.
14. Plebani M. Pepsinogens in health and disease. Crit. Rev. Clin. Lab. Sci. 1993; 30: 273-328.
15. Schlemper RJ, van der Werf SDJ, Vandenbroucke JP, Biemond I, Lamers CBHW. Seroepidemiology of gastritis in Japanese and Dutch working populations: Evidence for the development of atrophic gastritis that is not related to Helicobacter pylori. Gut 1995; 37: 199-204.
16. Miettinen O. Estimability and estimation in case-referent studies. Am. J. Epidemiol. 1976; 103: 226-35.
17. Feinstein AR. Clinical Epidemiology: The Architecture of Clinical Research. Philadelphia: Saunders, 1985.
18. Asaka M, Kimura T, Kudo M et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 760-6.
19. Tanaka Y, Mine K, Nakai Y, Mishima N, Nakagawa T. Serum pepsinogen I concentrations in peptic ulcer patients in relation to ulcer location and stage. Gut 1991; 32: 849-52.
20. Malesci A, Basilico M, Bersani M, Bonato C, Ballarin E, Ronchi G. Serum pepsinogen I elevation in cigarette smokers. Scand. J. Gastroenterol. 1988; 23: 602-6.
21. Correa P, Fox J, Fontham E et al. Helicobacter pylori and gastric carcinoma. Serum antibody prevalence in populations with contrasting cancer risks. Cancer 1990; 66: 2569-74.
22. Haldane JBS. The estimation and significance of the logarithm of a ratio of frequencies. Ann. Hum. Genetics 1955; 20: 309-11.
23. Inouye H, Yamamoto I, Tanida N et al. Campylobacter pylori in Japan: Bacteriological feature and prevalence in healthy subjects and patients with gastroduodenal disorders. Gastroenterol. Jpn. 1989; 24: 494-504.
24. Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 1988; 94: 33-40.
25. Graham DY, Adam E, Reddy GT et al. Seroepidemiology of Helicobacter pylori infection in India. Comparison of developing and developed countries. Dig. Dis. Sci. 1991; 36: 1084-8.
26. Mégraud F, Brassens-Rabbé M-P, Denis F, Belbouri A, Hoa DQ. Seroepidemiology of Campylobacter pylori infection in various populations. J. Clin. Microbiol. 1989; 27: 1870-3.
27. Sobala GM, Crabtree JE, Pentith JA et al. Screening dyspepsia by serology to Helicobacter pylori. Lancet 1991; 338: 94-6.
28. Mertz HR, Samloff IM, Rotter J, Peterson W, Walsh J. Helicobacter pylori seropositivity in a hyperpepsinogen 1 family. Gastroenterology 1991; 100: A12 (Abstract).
29. Mossi S, Meyer-Wyss B, Renner EL, Merki HS, Gamboni G, Beglinger C. Influence of Helicobacter pylori, sex, and age on serum gastrin and pepsinogen concentrations in subjects without symptoms and patients with duodenal ulcers. Gut 1993; 34: 752-6.
30. Walker P, Luther J, Samloff IM, Feldman M. Life events and psychosocial factors in men with peptic ulcer disease. II. Relationships with serum pepsinogen concentrations and behavioral risk factors. Gastroenterology 1988; 94: 323-30.
31. Peters MN, Richardson CT. Stressful life events, acid hypersecretion, and ulcer disease. Gastroenterology 1983; 84: 114-19.
32. Samloff IM, Stemmermann GN, Heilbrun LK, Nomura A. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology 1986; 90: 570-6.
33. Kekki M, Sipponen P, Siurala M. Progression of antral and body gastritis in patients with active and healed duodenal ulcer and duodenitis. Scand. J. Gastroenterol. 1984; 19: 382-8.
34. Araki S, Goto Y. Peptic ulcer in male factory workers: A survey of prevalence, incidence, and aetiological factors. J. Epidemiol. Community Health 1985; 39: 82-5.
35. Ostensen H, Gudmundsen TE, Ostensen M, Burhol PG, Bonnevie O. Smoking, alcohol, coffee, and familial factors: Any associations with peptic ulcer disease? A clinically and radiologically prospective study. Scand. J. Gastroenterol. 1985; 20: 1227-35.
36. Piper DW, Nasiry R, McIntosh J, Shy CM, Pierce J, Byth K. Smoking, alcohol, analgesics, and chronic duodenal ulcer. A controlled study of habits before first symptoms and before diagnosis. Scand. J. Gastroenterol. 1984; 19: 1015-21.
37. Cohen S, Booth GH. Gastric acid secretion and lower-esophageal-sphincter pressure in response to coffee and caffeine. N. Engl. J. Med. 1975; 293: 897-9.
38. Kuipers EJ, Peña AS, van Kamp G et al. Seroconversion of Helicobacter pylori. Lancet 1993; 342: 328-31.